VNO Stock Recent News

Kevin Maloney, founder and CEO at PMG, joins CNBC's ‘The Exchange' to discuss his 2025 commercial real estate outlooks, top real estate trends to watch, and more.

The U.S. office real estate market is likely poised for a rebound with high demand for premium office spaces backed by a strong economy.

Caveat Emptor series aims to help investors avoid “sucker yields,” “value traps,” and “ugly ducklings” by highlighting risks and conducting due diligence. Dynex Capital is rated a sell due to poor operational performance, negative EPS, and unsustainable dividend payout ratios. Vornado Realty Trust is rated a sell due to declining AFFO, high geographic concentration risks, and a history of value erosion.

NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Vornado Realty Trust (NYSE:VNO) announced today that its Board of Trustees has declared a dividend of $.74 per common share. The dividend will be payable on December 27, 2024 to shareholders of record on December 16, 2024.

Vornado (VNO) reported earnings 30 days ago. What's next for the stock?

VNO's premium assets in select high-rent markets and portfolio-repositioning efforts augur well despite ongoing choppiness in the office real estate market.

Tenants' healthy demand for premier office spaces and portfolio-repositioning initiatives is well-poised to support VNO's performance.

Manhattan is experiencing a generational wave of office-to-residential conversions that are taking the supply of office space off the market. Vornado Series O Preferreds are trading at just under 66 cents on the dollar. Leasing is strong, with VNO expecting its portfolio occupancy rate to rise on the back of recent leases.

VNO securing of lease expansion with Medline at THE MART, Chicago, highlights healthy demand for the office-space building.

Medline's 161,000 SF Lease Makes the Growing Healthcare Company One of THE MART's Largest Tenants Medline's 161,000 SF Lease Makes the Growing Healthcare Company One of THE MART's Largest Tenants